International Society for Cellular Oncology

Publications in biomedical science follow a vicious circle. The better the papers that are published in a journal, the more they are cited, the higher the impact factor of that journal will be, and thus the more attractive it is for authors of good papers to submit their manuscripts to that journal. Many members of ISCO are facing situations where impact factors of journals in which they publish have a major influence on their chances of successfully applying for research grants. In fact, this means that many of us not automatically will submit their manuscripts to a journal with an impact factor of 1.2, like Cellular Oncology. Despite this, the editor, associate editors and editorial board of Cellular Oncology have accepted the challenge to position Cellular Oncology as an attractive platform for publishing scientific communications in the field of oncology. With the present issue we feel that we certainly have succeeded, and we want to stimulate you to help us succeed in the future as well. One way of doing this is by showing the ISCO members that Cellular Oncology papers, and in the past Analytical Cellular Pathology papers, have a potential of being cited quite well. To this end we here provide you with an overview of the most cited papers of the last five years, stratified by year. This proves that publishing in Cellular Oncology, which is listed in Medline, certainly is an excellent option to reach a large readership.